Table 1. Baseline demographics of the patients.
| Parameter | Mean ± SD (N = 39) | Mean ± SD (N = 6) | Mean ± SD (N = 45) |
|---|---|---|---|
| Age (years) | 35.10 (± 13.84) | 24.71(± 9.44) | 33.52 (± 13.68) |
| Weight (kg) | 72.27 (±19.22) | 63.26 (±21.32) | 70.77 (±19.60) |
| Race (W/B/O) | 27/11/1 (69%/28%/3%) | 5/2 (71.4%/28.6%) | 32/13/1 (69.5%/28.3%/2.2%) |
| Ethnicity (Hispanic/Non-Hispanic) | 16/23 (41%/59%) | 2/5 (28.6%/71.4%) | 18/28 (39.1%/60.9%) |
| Gender (M/F) | 26/13 (67%/33%) | 3/4 (42.8%/57.2%) | 29/17(63%/37%) |
| Donor (LD/DD) | 25/14 (64%/36%) | 7/0 (100%/0%) | 32/14 (70%/30%) |
| Time to ESRD | 4.25 (±4.18) | 4.82 (±3.54) (N = 5) | 4.44 (±4.33) |
N = 45 with N = 39 enrolled in this study, N = 6 enrolled in a previous study[5]. End-stage renal disease (ESRD) is defined as GFR < 15 ml/min/1.73 m2 or dialysis.